Cargando…

Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries)

BACKGROUND: Mortality from epizootic pneumonia is hindering re-establishment of bighorn sheep populations in western North America. Mycoplasma ovipneumoniae, a primary agent of this disease, is frequently carried asymptomatically by the domestic sheep and goats that constitute the reservoir of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziegler, Jessie C., Lahmers, Kevin K., Barrington, George M., Parish, Steven M., Kilzer, Katherine, Baker, Katherine, Besser, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994082/
https://www.ncbi.nlm.nih.gov/pubmed/24752006
http://dx.doi.org/10.1371/journal.pone.0095698
_version_ 1782312664963219456
author Ziegler, Jessie C.
Lahmers, Kevin K.
Barrington, George M.
Parish, Steven M.
Kilzer, Katherine
Baker, Katherine
Besser, Thomas E.
author_facet Ziegler, Jessie C.
Lahmers, Kevin K.
Barrington, George M.
Parish, Steven M.
Kilzer, Katherine
Baker, Katherine
Besser, Thomas E.
author_sort Ziegler, Jessie C.
collection PubMed
description BACKGROUND: Mortality from epizootic pneumonia is hindering re-establishment of bighorn sheep populations in western North America. Mycoplasma ovipneumoniae, a primary agent of this disease, is frequently carried asymptomatically by the domestic sheep and goats that constitute the reservoir of this agent for transmission to bighorn sheep. Our long-term objective is to reduce the risk of M. ovipneumoniae infection of bighorn sheep; one approach to this objective is to control the pathogen in its reservoir hosts. METHODS: The safety and immunogenicity of M. ovipneumoniae for domestic sheep was evaluated in three experimental immunization protocols: 1) live M. ovipneumoniae (50 ug protein); 2) killed M. ovipneumoniae (50 ug whole cell protein) in oil adjuvant; and 3) killed M. ovipneumoniae (250 ug whole cell protein) in oil adjuvant. Immunogenicity was assessed by two serum antibody measures: competitive enzyme-linked immunosorbent assay (cELISA) (experiments 1–3) and serum growth inhibition (Experiment 3). Passive immunogenicity was also assessed in the third experiment using the same assays applied to blood samples obtained from the lambs of immunized ewes. RESULTS AND CONCLUSIONS: Adverse reactions to immunization were generally minor, but local reactions were regularly observed at immunization sites with bacterins in oil adjuvants. No evidence of M. ovipneumoniae specific antibody responses were observed in the first or second experiments and no resistance to colonization was observed in the first experiment. However, the ewes in the third experiment developed strong cELISA serum antibody responses and significant serum M. ovipneumoniae inhibition activity, and these responses were passively transferred to their lambs. The results of these trials indicate that immunization with relatively large antigenic mass combined with an adjuvant is capable of inducing strong active antibody responses in ewes and passively immunizing lambs.
format Online
Article
Text
id pubmed-3994082
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39940822014-04-25 Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries) Ziegler, Jessie C. Lahmers, Kevin K. Barrington, George M. Parish, Steven M. Kilzer, Katherine Baker, Katherine Besser, Thomas E. PLoS One Research Article BACKGROUND: Mortality from epizootic pneumonia is hindering re-establishment of bighorn sheep populations in western North America. Mycoplasma ovipneumoniae, a primary agent of this disease, is frequently carried asymptomatically by the domestic sheep and goats that constitute the reservoir of this agent for transmission to bighorn sheep. Our long-term objective is to reduce the risk of M. ovipneumoniae infection of bighorn sheep; one approach to this objective is to control the pathogen in its reservoir hosts. METHODS: The safety and immunogenicity of M. ovipneumoniae for domestic sheep was evaluated in three experimental immunization protocols: 1) live M. ovipneumoniae (50 ug protein); 2) killed M. ovipneumoniae (50 ug whole cell protein) in oil adjuvant; and 3) killed M. ovipneumoniae (250 ug whole cell protein) in oil adjuvant. Immunogenicity was assessed by two serum antibody measures: competitive enzyme-linked immunosorbent assay (cELISA) (experiments 1–3) and serum growth inhibition (Experiment 3). Passive immunogenicity was also assessed in the third experiment using the same assays applied to blood samples obtained from the lambs of immunized ewes. RESULTS AND CONCLUSIONS: Adverse reactions to immunization were generally minor, but local reactions were regularly observed at immunization sites with bacterins in oil adjuvants. No evidence of M. ovipneumoniae specific antibody responses were observed in the first or second experiments and no resistance to colonization was observed in the first experiment. However, the ewes in the third experiment developed strong cELISA serum antibody responses and significant serum M. ovipneumoniae inhibition activity, and these responses were passively transferred to their lambs. The results of these trials indicate that immunization with relatively large antigenic mass combined with an adjuvant is capable of inducing strong active antibody responses in ewes and passively immunizing lambs. Public Library of Science 2014-04-21 /pmc/articles/PMC3994082/ /pubmed/24752006 http://dx.doi.org/10.1371/journal.pone.0095698 Text en © 2014 Ziegler et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ziegler, Jessie C.
Lahmers, Kevin K.
Barrington, George M.
Parish, Steven M.
Kilzer, Katherine
Baker, Katherine
Besser, Thomas E.
Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries)
title Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries)
title_full Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries)
title_fullStr Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries)
title_full_unstemmed Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries)
title_short Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries)
title_sort safety and immunogenicity of a mycoplasma ovipneumoniae bacterin for domestic sheep (ovis aries)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994082/
https://www.ncbi.nlm.nih.gov/pubmed/24752006
http://dx.doi.org/10.1371/journal.pone.0095698
work_keys_str_mv AT zieglerjessiec safetyandimmunogenicityofamycoplasmaovipneumoniaebacterinfordomesticsheepovisaries
AT lahmerskevink safetyandimmunogenicityofamycoplasmaovipneumoniaebacterinfordomesticsheepovisaries
AT barringtongeorgem safetyandimmunogenicityofamycoplasmaovipneumoniaebacterinfordomesticsheepovisaries
AT parishstevenm safetyandimmunogenicityofamycoplasmaovipneumoniaebacterinfordomesticsheepovisaries
AT kilzerkatherine safetyandimmunogenicityofamycoplasmaovipneumoniaebacterinfordomesticsheepovisaries
AT bakerkatherine safetyandimmunogenicityofamycoplasmaovipneumoniaebacterinfordomesticsheepovisaries
AT besserthomase safetyandimmunogenicityofamycoplasmaovipneumoniaebacterinfordomesticsheepovisaries